CLEVELAND (WJW)-– As the cost of life-saving insulin soars for people with diabetes, a Cleveland company is developing nanotechnology that could help.
The technology, from Diasome, makes insulin more effective in the body so less is needed to regulate blood sugar.
Insulin costs for patients with type one diabetes doubled between 2012 and 2016, according to the nonprofit Health Care Cost Institute.
The skyrocketing costs have led some patients to ration doses of life-saving insulin, according to Dr. Rose Gubitosi-Klug, Chief of Pediatric Endocrinology and Diabetes at UH Rainbow Babies & Children’s Hospital. She said, on a weekly basis, her staff encounters pediatric patients whose families are limiting dosage to try to save money and the results can be dangerous.
Click here to read the complete article.
Story excerpt provided by FOX8 Cleveland.
Written by Matt Wright.
Originally published December 10, 2019.